From Evidence to Impact

Medical Impact Ventures
  • 0.0 (0)
  • MEDICINE
  • SERIES

Translating Clinical Evidence Into Real-World Outcomes: In modern healthcare, there is no shortage of clinical evidence—yet a persistent gap remains between what we know and how care is actually delivered. From Evidence to Impact is a podcast dedicated to closing that gap—for physicians, healthcare providers, and patients alike. Hosted by Matthew H. Wayne, Founder and Managing Director of Medical Impact Ventures, this series brings together leading experts across oncology, rare disease, cardiology, and beyond to explore a central question: Why doesn’t evidence consistently change care—and what can we do to ensure it does? A New Model for Medical Education and Awareness: This is not a traditional medical podcast. Rather than summarizing guidelines, From Evidence to Impact focuses on how real decisions are made—in clinics, hospitals, and everyday patient experiences. Each episode uses expert dialogue and real-world scenarios to highlight: - Early signals that are often overlooked - Decision points where outcomes diverge - Practical strategies to improve diagnosis and care - Opportunities for patients to better understand and advocate for their health - The result is a format that is both clinically rigorous for providers and accessible and empowering for patients. - Closing Diagnostic and Care Gaps Signature series within the podcast focus on conditions where earlier recognition and better care pathways can significantly improve outcomes. One example is CATCH-TGCT, which explores Tenosynovial Giant Cell Tumor (TGCT)—a disease that often presents like a routine joint injury but follows a very different course. Patients may experience: - Persistent joint pain - Recurrent swelling - Reduced mobility Because these symptoms mimic common conditions, diagnosis is often delayed—sometimes for over a year—leading to unnecessary treatments, progression of disease, and increased patient burden. Through expert-led conversations, the series identifies the moments where recognition becomes possible: - When symptoms persist longer than expected - When swelling occurs without a clear cause - When the story doesn’t match the diagnosis - When it’s time to ask deeper questions or pursue advanced imaging From Evidence to Action Across every episode, one principle remains constant: Evidence alone does not change care—behavior does. Improving outcomes requires alignment between: - Clinical knowledge - Provider decision-making - Patient awareness and advocacy - Systems of care This podcast helps bridge those elements by translating complex evidence into clear, actionable insights for both clinicians and patients. Designed for Real-World Impact: From Evidence to Impact aligns with the most important priorities in healthcare today: - Evidence-based medicine - Quality improvement (QI) - Real-world evidence (RWE) - Implementation science - Patient-centered care It serves as a platform for improving how care is delivered—at scale. Who Should Listen: - Physicians across specialties - Nurse practitioners and physician assistants - Allied healthcare providers - Patients navigating complex or unclear diagnoses - Caregivers seeking to better understand medical decisions - Healthcare leaders and medical affairs professionals The Takeaway: Most medical decisions don’t fail because of a lack of knowledge. They fail because the right question wasn’t asked at the right time. From Evidence to Impact is about helping clinicians think differently—and helping patients recognize when something isn’t right—because the distance between evidence and impact is where outcomes are decided.

Season 1

  1. Episode 1: The Diagnostic Challenge

    EPISODE 1

    Episode 1: The Diagnostic Challenge

    Most joint complaints in sports medicine follow a predictable arc—an identifiable mechanism, swelling, imaging, and recovery. But what happens when that arc breaks? In this opening episode of the CATCH-TGCT series, we explore the early clinical moments when tenosynovial giant cell tumor (TGCT)—a rare but locally aggressive synovial tumor—first intersects with care. Often presenting with symptoms that mimic common injuries, TGCT blends seamlessly into the everyday landscape of sports medicine, contributing to diagnostic delays that can stretch well beyond a year. Joined by orthopedic sports medicine surgeon Dr. Ryan Freshman (UC Davis), this conversation brings listeners to the true front line of diagnosis: the initial clinical encounter. Here, the working assumption is almost always mechanical injury—and for good reason. But as Dr. Freshman explains, it’s the subtle deviations from expected recovery patterns that should prompt a shift in thinking. Key clinical insights emerge: - Persistent symptoms beyond six weeks should trigger reconsideration—and imaging becomes essential, not optional - Recurrent, atraumatic joint effusions that do not respond to conservative care are a critical red flag - When symptom patterns don’t align with mechanism, clinicians must broaden the differential Through real-world clinical reasoning, this episode highlights the “Gestalt” that develops with experience—recognizing when something simply doesn’t fit. It also reinforces practical, actionable habits: clearly communicating suspicion in MRI orders, directly engaging radiologists, and most importantly, listening carefully to the patient narrative. The episode then expands to a systems-level perspective with musculoskeletal oncologist Dr. R. Lor Randall, who reflects on what diagnostic delay looks like from the other end of the journey. While TGCT is often slow-growing, prolonged delays can lead to structural joint damage and more complex treatment pathways. His message is clear: if symptoms persist beyond three to six months, clinicians must pause and reconsider the diagnosis. Together, these perspectives reveal a unifying theme—TGCT is not missed because it is invisible, but because it appears familiar. This episode challenges clinicians to rethink time as a diagnostic signal. At some point, the question shifts from “What caused this?” to “Why hasn’t this resolved?” Because when duration outweighs mechanism, recognition becomes possible—and early action can change everything that follows.

    26 min
  2. Episode 2: Recognition and Differential Diagnosis

    EPISODE 2

    Episode 2: Recognition and Differential Diagnosis

    In Episode 2 of the CATCH-TGCT series, the focus shifts from recognition to action—what happens when persistent joint symptoms don’t follow the expected path, and how early decisions can dramatically change what comes next. When synovitis persists, biology doesn’t pause. Building on Episode 1, this conversation introduces a practical, frontline checklist for sports medicine clinicians to avoid treating TGCT like a routine injury for too long. Key warning signs include atraumatic or atypical joint swelling, symptoms that fail to improve with conservative care, and clinical presentations that don’t align with a clear mechanism. And when uncertainty remains, one message is repeated: if there’s no MRI, get the MRI. Orthopedic sports medicine perspectives highlight two critical mindset shifts. First, trust clinical intuition—real-world medicine is rarely black and white, and when something doesn’t feel right, it often isn’t. Second, avoid “burying your head in the sand.” Continuing conservative treatment in the face of persistent symptoms isn’t neutral—it’s a delay. The episode also emphasizes the importance of the broader care team. Athletic trainers and physical therapists—often the first to notice when recovery isn’t progressing—serve as an early warning system. Their input, combined with timely imaging and open communication, can accelerate diagnosis and prevent prolonged uncertainty. From a systems perspective, common barriers emerge: time constraints, high patient volume, and a clinical mindset trained to prioritize common diagnoses. Within 15-minute visits, rare conditions like TGCT can easily be overlooked—unless awareness shifts the default. Orthopedic oncology brings clarity to what’s at stake. When key clinical triggers are missed—persistent monoarticular swelling, recurrent effusions, discordance between history and presentation—the result is often delayed referral and more complex disease. A simple but powerful rule emerges: if symptoms persist beyond three to six months and don’t align with the expected diagnosis, it’s time to pause, rethink, and expand the differential. From the medical oncology perspective, the consequences of delay become even more tangible. While TGCT is technically benign, it is locally aggressive and can significantly impact quality of life—especially in young patients who may live with the disease for decades. Many arrive after years of symptoms and multiple surgeries, with joint damage, arthritis, and functional limitations already established. Earlier diagnosis changes everything. Patients identified early often return close to baseline with appropriate treatment. Those diagnosed later may face more complex care, longer recovery, and incomplete restoration of function. The difference isn’t just clinical—it’s lifelong. Across every perspective, one theme remains clear: TGCT is not dangerous because it spreads—it’s dangerous because it progresses. This episode challenges clinicians to recognize the inflection point—when recovery stalls, when patterns don’t fit, and when duration begins to outweigh mechanism. Because that moment—often subtle, often overlooked—is where better decisions begin.

    22 min
  3. Episode 3: Imaging, Referral, and Next Steps

    EPISODE 3

    Episode 3: Imaging, Referral, and Next Steps

    In the final episode of the CATCH-TGCT series, the focus turns to alignment—between clinical suspicion and radiologic interpretation, between imaging findings and referral pathways, and ultimately, between diagnosis and action. Because a scan alone doesn’t diagnose a patient—but the right scan, ordered with the right question, can end a diagnostic journey that might otherwise take years. Featuring a musculoskeletal radiologist, this episode explores a critical but often overlooked reality: radiologists are influenced by the clinical story they’re given. When imaging is ordered with a history of “sports injury,” rare conditions like TGCT may not even enter the differential. In many cases, TGCT appears as an incidental finding—easily mistaken for more common entities like intra-articular loose bodies, hemorrhage, or synovitis. Listeners gain practical, high-impact strategies to improve diagnostic accuracy: - How small changes in MRI order language (e.g., “question of mass”) can shift the radiologist’s search pattern - When contrast-enhanced MRI becomes essential—and how it differentiates TGCT from lookalike conditions - Why “non-specific” imaging findings should not be passively accepted when the clinical picture doesn’t align The episode also addresses a critical communication gap: what to do when the radiology report and the clinical story don’t match. The answer is simple but underutilized—pick up the phone. Direct dialogue between clinicians and radiologists can clarify ambiguity, prompt re-evaluation, and prevent missed diagnoses. From there, the conversation expands to what happens after suspicion becomes diagnosis. Medical oncology perspectives highlight the evolving treatment landscape, including surgery for localized disease and systemic therapies targeting CSF-1 for more diffuse cases. Importantly, not every patient requires immediate intervention—treatment decisions are highly individualized and guided by symptom burden and impact on quality of life. Across all perspectives, one principle stands out: TGCT is a complex, chronic condition that demands multidisciplinary care. Optimal outcomes depend on early collaboration between sports medicine, radiology, orthopedic oncology, and medical oncology—ensuring patients receive the right care at the right time. The most preventable delay? Imaging. When symptoms are attributed to injury and imaging is deferred, the diagnostic clock keeps ticking. A low threshold for MRI when recovery deviates from expectation remains one of the most actionable opportunities to improve care. This episode brings the series full circle, reinforcing a central theme: Recognition doesn’t happen in isolation—it happens through alignment. When clinical context, imaging interpretation, and multidisciplinary expertise come together early, the diagnostic pathway shortens, treatment options expand, and patient outcomes improve. Because in TGCT, the signal is there. It just needs to be seen—and connected.

    31 min
  • 3 Episodes

About

Translating Clinical Evidence Into Real-World Outcomes: In modern healthcare, there is no shortage of clinical evidence—yet a persistent gap remains between what we know and how care is actually delivered. From Evidence to Impact is a podcast dedicated to closing that gap—for physicians, healthcare providers, and patients alike. Hosted by Matthew H. Wayne, Founder and Managing Director of Medical Impact Ventures, this series brings together leading experts across oncology, rare disease, cardiology, and beyond to explore a central question: Why doesn’t evidence consistently change care—and what can we do to ensure it does? A New Model for Medical Education and Awareness: This is not a traditional medical podcast. Rather than summarizing guidelines, From Evidence to Impact focuses on how real decisions are made—in clinics, hospitals, and everyday patient experiences. Each episode uses expert dialogue and real-world scenarios to highlight: - Early signals that are often overlooked - Decision points where outcomes diverge - Practical strategies to improve diagnosis and care - Opportunities for patients to better understand and advocate for their health - The result is a format that is both clinically rigorous for providers and accessible and empowering for patients. - Closing Diagnostic and Care Gaps Signature series within the podcast focus on conditions where earlier recognition and better care pathways can significantly improve outcomes. One example is CATCH-TGCT, which explores Tenosynovial Giant Cell Tumor (TGCT)—a disease that often presents like a routine joint injury but follows a very different course. Patients may experience: - Persistent joint pain - Recurrent swelling - Reduced mobility Because these symptoms mimic common conditions, diagnosis is often delayed—sometimes for over a year—leading to unnecessary treatments, progression of disease, and increased patient burden. Through expert-led conversations, the series identifies the moments where recognition becomes possible: - When symptoms persist longer than expected - When swelling occurs without a clear cause - When the story doesn’t match the diagnosis - When it’s time to ask deeper questions or pursue advanced imaging From Evidence to Action Across every episode, one principle remains constant: Evidence alone does not change care—behavior does. Improving outcomes requires alignment between: - Clinical knowledge - Provider decision-making - Patient awareness and advocacy - Systems of care This podcast helps bridge those elements by translating complex evidence into clear, actionable insights for both clinicians and patients. Designed for Real-World Impact: From Evidence to Impact aligns with the most important priorities in healthcare today: - Evidence-based medicine - Quality improvement (QI) - Real-world evidence (RWE) - Implementation science - Patient-centered care It serves as a platform for improving how care is delivered—at scale. Who Should Listen: - Physicians across specialties - Nurse practitioners and physician assistants - Allied healthcare providers - Patients navigating complex or unclear diagnoses - Caregivers seeking to better understand medical decisions - Healthcare leaders and medical affairs professionals The Takeaway: Most medical decisions don’t fail because of a lack of knowledge. They fail because the right question wasn’t asked at the right time. From Evidence to Impact is about helping clinicians think differently—and helping patients recognize when something isn’t right—because the distance between evidence and impact is where outcomes are decided.

Information

  • Creator
    Medical Impact Ventures
  • Episodes
    3
  • Seasons
    1